Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PAAD | rs1316471 | chr7:51542081 | C/T | 0 | 178 | 15.77 | 13.1 | 1.03 | KM Plot |
PAAD | rs13191362 | chr6:163033350 | A/G | 0.000142 | 178 | 15.57 | 14.33 | 6.03 | KM Plot |
PAAD | rs13252399 | chr8:1815012 | A/T | 7.2E-6 | 178 | 16.92 | 13.03 | 6.02 | KM Plot |
PAAD | rs13267804 | chr8:1813692 | C/T | 5.62E-6 | 174 | 16.6 | 12.7 | 6.02 | KM Plot |
PAAD | rs13272734 | chr8:1817756 | C/G | 4.0E-5 | 173 | 16.17 | 13.03 | 6.02 | KM Plot |
PAAD | rs13277172 | chr8:1821137 | T/G | 3.26E-5 | 175 | 16.27 | 13.13 | 6.02 | KM Plot |
PAAD | rs13281104 | chr8:1811923 | A/G | 1.27E-6 | 170 | 17.23 | 12.7 | 6.02 | KM Plot |
PAAD | rs13296785 | chr9:37258316 | A/G | 6.52E-5 | 178 | 3.9 | 15.67 | 15.38 | KM Plot |
PAAD | rs13355233 | chr5:127425350 | A/G | 0.000152 | 178 | 7.87 | 13.95 | 16.17 | KM Plot |
PAAD | rs13386645 | chr2:240848546 | C/G | 4.04E-6 | 175 | 15.77 | 14.48 | 4.47 | KM Plot |
PAAD | rs13392238 | chr2:217895082 | C/T | 0.000141 | 178 | 16.07 | 14.47 | 7.2 | KM Plot |
PAAD | rs13394296 | chr2:70429234 | T/C | 0 | 178 | 15.37 | 17.4 | 1.03 | KM Plot |
PAAD | rs13400654 | chr2:240848547 | A/G | 4.04E-6 | 175 | 15.77 | 14.48 | 4.47 | KM Plot |
PAAD | rs13402257 | chr2:240846539 | G/A | 9.52E-6 | 171 | 15.67 | 14.18 | 4.47 | KM Plot |
PAAD | rs13403416 | chr2:70429052 | A/G | 0 | 178 | 15.37 | 17.4 | 1.03 | KM Plot |